Compound Profiles
MOTS-c
Mitochondrial-Derived Peptide | Metabolic Regulator
Inhibits the folate cycle leading to AMPK activation. Under metabolic stress, translocates to nucleus to bind stress-response transcription factors, regulating genes involved in metabolism, insulin sensitivity, and cellular adaptation.
Tesamorelin
GHRH Analog | Visceral Fat Reduction
Subcutaneous injection provides optimal bioavailability for GHRH receptor binding and pulsatile GH release stimulation, selectively targeting visceral adipose tissue while sparing subcutaneous fat..
Combined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take MOTS-c with Tesamorelin?
Yes, MOTS-c and Tesamorelin can generally be taken together. MOTS-c helps counteract the insulin-disrupting effects of Tesamorelin. A smart combination — the insulin sensitizer mitigates metabolic side effects.
Is MOTS-c and Tesamorelin safe together?
Based on pharmacological analysis, this combination is considered synergistic. However, shared safety flags include: insulin disrupting, teratogenic. Monitor accordingly.
What are the interactions between MOTS-c and Tesamorelin?
MOTS-c helps counteract the insulin-disrupting effects of Tesamorelin. A smart combination — the insulin sensitizer mitigates metabolic side effects. This assessment has 51% confidence and is inferred from pharmacological mechanism analysis.
How should I time MOTS-c and Tesamorelin?
MOTS-c has a half-life of ~30 minutes and Tesamorelin has a half-life of 26-38 minutes. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.